FDA approves once-weekly insulin injection for type 2 diabetes
Most outlets reported the FDA's approval of Eli Lilly’s once-weekly insulin for type 2 diabetes, highlighting its potential as an alternative to daily injections. The News International added context about the drug being a basal insulin for adults, while BOL News described it as a "breakthrough" and briefly noted its use in conjunction with diet and exercise.
Summary generated by HarZaviya from the headlines and excerpts of the 2 outlets below. Each outlet's own headline is listed under it.
Same story from 2 outlets
Each outlet's own headline, most recent first — read any at its source.
-
FDA approves Lilly’s once-weekly insulin injection for type 2 diabetes
FDA approves Lilly's Onswik, a new once-weekly insulin injection, for type 2 diabetes. This breakthrough helps control high blood sugar with diet & exercise.
-
New once-weekly insulin injection for type 2 diabetes wins FDA approval
The US Food and Drug Administration has officially approved Eli Lilly’s once-weekly basal insulin for adults with type 2 diabetes- a move that offers patients an alternative to daily long-acting insulin...
3 articles from 2 outlets, 24 Sep–24 Sep 2026. Headlines and links belong to their outlets — HarZaviya links out and never copies article text. What does % identical mean?